June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Reduced-Dose Indocyanine Green Photodynamic Therapy (iPDT) as an Optimized Treatment for Chronic Central Serous Chorioretinopathy
Author Affiliations & Notes
  • Jose A Cardillo
    Retina Department, Hospital de Olhos de Araraquara, Araraquara, Brazil
    Retina, Ribeirão Preto Medical School-University of São Paulo, Ribeirão Preto, Brazil
  • Leticia Barroso
    Retina, Ribeirão Preto Medical School-University of São Paulo, Ribeirão Preto, Brazil
  • Murilo Wendeborn Rodrigues
    Retina, Ribeirão Preto Medical School-University of São Paulo, Ribeirão Preto, Brazil
  • Rodrigo Jorge
    Retina, Ribeirão Preto Medical School-University of São Paulo, Ribeirão Preto, Brazil
  • Acacio Lima
    Retina Department, Hospital de Olhos de Araraquara, Araraquara, Brazil
    Escola Paulista de Medicina, São Paulo, Brazil
  • Footnotes
    Commercial Relationships Jose Cardillo, None; Leticia Barroso, None; Murilo Rodrigues, None; Rodrigo Jorge, None; Acacio Lima, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 201. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Jose A Cardillo, Leticia Barroso, Murilo Wendeborn Rodrigues, Rodrigo Jorge, Acacio Lima; Reduced-Dose Indocyanine Green Photodynamic Therapy (iPDT) as an Optimized Treatment for Chronic Central Serous Chorioretinopathy. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):201.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To assess the efficacy and safety of reduced-dose Indocyanine green photodynamic therapy (iPDT) in patients with chronic central serous chorioretinopathy (CCSC) with no spontaneous resolution 6 months after the onset of the disease.

 
Methods
 

Twelve patients with CCSC presenting with persistent subretinal fluid in optical coherence tomography (OCT) six months after presentation and decrease in visual acuity (VA) were submitted to a single iPDT session with 1.5 mg/kg body weight indocynine green (ICG) and application of 4.5 W/cm2 light at 810 nm. A continuous follow-up was provided with best-corrected ETDRS VA assessment, and angiographic and OCT documentation 72 hours before and at 7 days, 1 and 2 weeks, 1, 3, 6, and 12 months after treatment.

 
Results
 

Ten out of twelve patients presented with VA levels of ≥20/25 2 weeks after treatment; the mean logMAR VA change of 0.345 at that time was statistically significant (p < 0.05, Friedman test). OCT disclosed resolution of persistent sub-retinal fluid in all eyes. No recurrence was observed after 12 months of follow-up. No treatment-related complications were observed during the study period.

 
Conclusions
 

Photodynamic therapy using low-intensity 810nm light to direct laser energy continuously at the active leakage sites after intravenous ICG infusion induced rapid and sustained VA recovery in patients with CCSC. In parallel with to new pharmacologic agents for the treatment of CCSC, developments in new laser technologies, exploiting optimized parameters and treatment guidelines will be the key to progress CCSC treatment approaches for an ultimate anatomical and functional restoration

 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×